| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |